|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
A news article has been posted about Immutep on the AFR. The article was published around , on 30 November 2020 at 3:24pm.
The Australian late-stage biotech has inked its second deal in a month – a Swiss-based biotech aiming to treat blood cancers and immunodeficiency diseases.
Read ArticleIMM was $0.27 at the close of trade on 27 November 2020
Find all articles about Immutep, including others on the AFR, on the media page.
You must be logged in to post a reply.
